Anixa Financial Statements From 2010 to 2026

ANIX Stock  USD 3.15  0.03  0.94%   
Anixa Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Anixa Biosciences' valuation are provided below:
Market Capitalization
104.7 M
Enterprise Value Revenue
368.9827
Earnings Share
(0.34)
We have found one hundred twenty available fundamental signals for Anixa Biosciences, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Anixa Biosciences prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 138 M in 2026. Enterprise Value is likely to drop to about 132 M in 2026

Anixa Biosciences Total Revenue

210,000

Check Anixa Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anixa Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 216.9 K, Selling General Administrative of 9 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 847, Dividend Yield of 0.0 or PTB Ratio of 6.1. Anixa financial statements analysis is a perfect complement when working with Anixa Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Anixa Stock
Check out the analysis of Anixa Biosciences Correlation against competitors.
For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Anixa Biosciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets26.1 M24.8 M15 M
Slightly volatile
Other Current Liabilities2.3 M2.2 M1.1 M
Slightly volatile
Total Current LiabilitiesM2.9 M1.7 M
Slightly volatile
Property Plant And Equipment Net133.4 K206.1 K137.7 K
Slightly volatile
Cash1.4 M1.5 M4.6 M
Pretty Stable
Non Current Assets Total250.2 K263.4 K1.2 M
Slightly volatile
Cash And Short Term Investments24.1 M22.9 M13.1 M
Slightly volatile
Common Stock Shares Outstanding38.5 M36.7 M20.4 M
Slightly volatile
Liabilities And Stockholders Equity26.1 M24.8 M15 M
Slightly volatile
Other Current Assets1.2 M1.1 M502.8 K
Slightly volatile
Other Stockholder Equity314.5 M299.5 M195 M
Slightly volatile
Total Liabilities2.3 M3.1 MM
Slightly volatile
Property Plant And Equipment Gross133.4 K206.1 K137.7 K
Slightly volatile
Total Current Assets25.8 M24.6 M13.8 M
Slightly volatile
Net Receivables209.7 K155.7 K289.4 K
Slightly volatile
Accounts Payable413.1 K472.5 K390.8 K
Pretty Stable
Non Current Liabilities Total221.8 K233.4 K1.5 M
Slightly volatile
Common Stock Total Equity264.2 K278.1 K576.6 K
Slightly volatile
Short Term Investments22.5 M21.5 M8.7 M
Slightly volatile
Common Stock275.3 K289.8 K579.1 K
Slightly volatile
Property Plant Equipment256 K243.8 K146 K
Slightly volatile
Current Deferred Revenue1.3 M1.4 M1.2 M
Very volatile
Short and Long Term Debt Total198.4 K208.8 K1.5 M
Slightly volatile
Other Liabilities3.2 M4.8 M3.7 M
Slightly volatile
Capital Surpluse181.1 M284.2 M192 M
Slightly volatile
Long Term Investments3.8 M3.8 M4.3 M
Slightly volatile
Non Current Liabilities Other149.6 K157.5 K1.6 M
Slightly volatile
Long Term Debt Total319.5 K630.9 K479.2 K
Slightly volatile
Short Term Debt24.8 K26.1 K233.8 K
Slightly volatile
Net Invested Capital18.7 M23 M14.4 M
Slightly volatile
Net Working Capital17.6 M21.7 M13.1 M
Slightly volatile
Capital Stock295 K370.3 K246.4 K
Slightly volatile
Capital Lease Obligations207.4 K266.8 K126.2 K
Slightly volatile

Anixa Biosciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General AdministrativeM8.6 M6.1 M
Slightly volatile
Other Operating Expenses16.7 M15.9 M10.7 M
Slightly volatile
Total Operating Expenses16.7 M15.9 M10.2 M
Slightly volatile
Depreciation And Amortization40.4 K42.5 K158.3 K
Slightly volatile
Research Development3.8 M7.4 M4.1 M
Slightly volatile
Interest Income1.4 M1.3 M498.8 K
Slightly volatile
Reconciled Depreciation31.6 K33.3 K221.6 K
Slightly volatile

Anixa Biosciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow999.6 K1.1 M4.4 M
Pretty Stable
Depreciation40.4 K42.5 K215.9 K
Slightly volatile
End Period Cash Flow1.4 M1.5 M4.6 M
Pretty Stable
Stock Based Compensation4.4 M5.1 M4.2 M
Slightly volatile
Change To Netincome3.9 M7.7 M4.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio847536264
Slightly volatile
Dividend Yield0.00.01.0E-4
Slightly volatile
Days Sales Outstanding443422194
Slightly volatile
Average Payables557.4 K470.5 K506.8 K
Slightly volatile
Stock Based Compensation To Revenue19.918.9510.8718
Slightly volatile
Capex To Depreciation0.190.20.2462
Slightly volatile
EV To Sales821532254
Slightly volatile
Sales General And Administrative To Revenue28.3126.9614.8115
Slightly volatile
Average Inventory202.1 K212.8 K361.2 K
Slightly volatile
Research And Ddevelopement To Revenue21.4620.4410.3053
Slightly volatile
Capex To Revenue0.660.630.4024
Slightly volatile
Cash Per Share1.380.720.6862
Pretty Stable
Intangibles To Total Assets0.280.150.2055
Slightly volatile
Current Ratio5.987.698.2021
Slightly volatile
Receivables Turnover0.670.79.5 K
Pretty Stable
Capex Per Share8.0E-48.0E-40.0055
Slightly volatile
Average Receivables1.2 K1.3 K81.3 K
Slightly volatile
Revenue Per Share0.00580.00614.8943
Pretty Stable
Interest Debt Per Share0.00790.00840.1456
Slightly volatile
Debt To Assets0.01170.01240.2357
Slightly volatile
Ebt Per Ebit0.870.831.0593
Slightly volatile
Long Term Debt To Capitalization1.212.242.2282
Pretty Stable
Quick Ratio5.87.698.8156
Pretty Stable
Net Income Per E B T1.11.141.0081
Slightly volatile
Cash Ratio0.560.584.7658
Pretty Stable
Days Of Sales Outstanding443422194
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.121.151.024
Slightly volatile
Fixed Asset Turnover1.081.14726
Pretty Stable
Debt Ratio0.01170.01240.2357
Slightly volatile
Price Sales Ratio847536264
Slightly volatile
Asset Turnover0.0070.00744.8991
Pretty Stable
Gross Profit Margin0.250.270.4282
Slightly volatile

Anixa Biosciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap138 M167.3 M91.1 M
Slightly volatile
Enterprise Value132 M134.1 M78.3 M
Slightly volatile

Anixa Fundamental Market Drivers

Anixa Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
12th of June 2024
Next Financial Report
View
31st of January 2024
Next Fiscal Quarter End
View
21st of January 2025
Next Fiscal Year End
View
31st of October 2023
Last Quarter Report
View
31st of October 2023
Last Financial Announcement
View

About Anixa Biosciences Financial Statements

Anixa Biosciences investors use historical fundamental indicators, such as Anixa Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Anixa Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.4 M1.3 M
Cost Of Revenue42.5 K40.4 K
Stock Based Compensation To Revenue 18.95  19.90 
Sales General And Administrative To Revenue 26.96  28.31 
Research And Ddevelopement To Revenue 20.44  21.46 
Capex To Revenue 0.63  0.66 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(60.30)(57.28)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.